The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 George Rho - Abstracts
| The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 George Rho | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Affymetrix Inc.(stock price appreciation potential) | Business, general | George Rho | |||
| Affymetrix Inc.(stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| Albany Molecular.(stock price appreciation potential; Albany Molecular Research Inc.) | Business, general | George Rho | |||
| Apria Healthcare.(stock price appreciation potential for Apria Healthcare Group, Inc.) | Business, general | George Rho | |||
| Biotechnology industry.(analysis of securities) | Business, general | George Rho, Charles Clark, Keith A. Markey, Randy Shrikishun, Andre J. Costanza, Susan J. Ferrara, Jerry W. Gray, John D. Burke | |||
| Biotechnology industry.(analysis of securities) | Business, general | George Rho, Charles Clark, Keith A. Markey, Randy Shrikishun, Andre J. Costanza, Susan J. Ferrara, Jerry W. Gray, Nira Maharaj | |||
| Boston Scientific.(stock price appreciation potential) | Business, general | George Rho | |||
| Boston Scientific.(stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| Dentsply Internt'l.(Dentsply International Inc., stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| Dentsply Internt'l.(stock price appreciation potential; Dentsply International Inc.) | Business, general | George Rho | |||
| Drug industry. | Business, general | George Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer | |||
| Drug industry.(analysis of securities) | Business, general | George Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, Frederick L. Harris, Susan J. Ferrara, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer | |||
| Drug industry.(securities analysis as of July 20, 2007)(Industry overview) | Business, general | George Rho, Mario Ferro, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, William C. Lewittes | |||
| Exelixis, Inc.(stock price appreciation potential) | Business, general | George Rho | |||
| Forest Labs.(stock price appreciation potential; Forest Laboratories Inc.) | Business, general | George Rho | |||
| Genomic Health.(stock price appreciation potential) | Business, general | George Rho | |||
| Genomic Health.(stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| Gilead Sciences.(stock price appreciation potential) | Business, general | George Rho | |||
| Illumina Inc.(stock price appreciation potential) | Business, general | George Rho | |||
| Illumina, Inc.(stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| ImClone Systems.(stock price appreciation potential) | Business, general | George Rho | |||
| Lilly (Eli) and Co.(stock price appreciation potential) | Business, general | George Rho | |||
| Medical services industry.(analysis of securities) | Business, general | George Rho, Mario Ferro, Randy Shrikishun, Susan J. Ferrara, Ian Gendler, Douglas G. Maurer, Jerry W. Gray, John D. Burke, Erik A. Manning | |||
| Medical services industry.(analysis of securities) | Business, general | George Rho, Mario Ferro, Erik M. Manning, Randy Shrikishun, Susan J. Ferrara, Ian Gendler, Douglas G. Maurer, Jerry W. Gray, Nira Maharaj, Gorge Rho | |||
| Medical supplies industry.(analysis of securities) | Business, general | Kenneth A. Nugent, George Rho, Keith A. Markey, Nils C. Van Liew, Andre J. Costanza, Iason Dalavagas, Erik A. Antonson, Greg McGowan, Tom Nikic, Christopher Robertson, Jerry W. Gray | |||
| Medical supplies industry.(securities' industry) | Business, general | Kenneth A. Nugent, George Rho, Keith A. Markey, Nils C. Van Liew, Andre J. Costanza, Iason Dalavagas, Erik A. Antonson, Greg McGowan, Tom Nikic, Christopher Robertson, Jerry W. Gray | |||
| Medtronic Inc.(stock price appreciation potential) | Business, general | George Rho | |||
| Medtronic, Inc.(stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| Mentor Corp.(stock price appreciation potential) | Business, general | George Rho | |||
| Mentor Corp.(stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| Millennium Pharm.(stock price appreciation potential of Millennium Pharmaceuticals, Inc.) | Business, general | George Rho | |||
| Newspaper industry.(analysis of securities) | Business, general | George Rho, Mario Ferro, Sigourney B. Romaine, Jeremy J. Butler, Richard Gallagher, Orly Seidman | |||
| Newspaper industry.(anlaysis of securities) | Business, general | George Rho, Mario Ferro, Sigourney B. Romaine, Jeremy J. Butler, Richard Gallagher, Orly Seidman | |||
| NightHawk Rad'ogy.(stock price appreciation potential of NightHawk Radiology Holdings, Inc.) | Business, general | George Rho | |||
| Par Pharm.(stock price appreciation potential; Par Pharmaceutical Companies Inc.) | Business, general | George Rho | |||
| Pediatrix Medical.(stock price appreciation potential) | Business, general | George Rho | |||
| Schein (Henry) Inc.(stock price appreciation potential) | Business, general | George Rho | |||
| Schein (Henry) Inc.(stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| Schering-Plough.(stock price appreciation potential) | Business, general | George Rho | |||
| Sepracor, Inc.(stock price appreciation potential) | Business, general | George Rho | |||
| Stryker Corp.(stock price appreciation potential) | Business, general | George Rho | |||
| Stryker Corp.(stock price appreciation potential)(Analyst report) | Business, general | George Rho | |||
| Tenet Healthcare.(stock price appreciation potential) | Business, general | George Rho | |||
| Universal Health.(stock price appreciation potential of Universal Health Services, Inc.) | Business, general | George Rho | |||
| Valeant Pharmac.(stock price appreciation potential; Valeant Pharmaceuticals) | Business, general | George Rho | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.